Business Context and Reporting Period
Company: Eastman Kodak Company (KODK)
Filing Type: Form 8-K (Current Report)
Date of Report: November 20, 2024
Subject: Entry into material definitive agreements regarding the sale of illiquid assets held by the Kodak Retirement Income Plan (KRIP) and the potential termination of the plan.
Key Financial Metrics and Transaction Details
This filing details asset sales and projected cash flows related to the KRIP Trust, not Kodak's operating revenue or profit.
- Primary Asset Sale: Agreement with Mastercard Foundation to sell KRIP illiquid assets with a net asset value (NAV) of $764.4 million (as of March 31, 2024) for a purchase price of $550.6 million in cash.
- Secondary Asset Sales: Agreements with four other investors to sell assets with a NAV of $87.3 million for $61.7 million (with $15.3 million deferred to December 31, 2025).
- Remaining Illiquid Assets: Post-transaction, the Trust expects to hold illiquid assets with a NAV of $161.3 million (as of September 30, 2024).
- Hedge Fund Assets: KRIP holds hedge fund assets with a NAV of $917.2 million (as of September 30, 2024), which are being redeemed.
- Projected Surplus: Estimated KRIP surplus assets after satisfying liabilities range from $885 million to $975 million.
- Projected Reversion to Kodak: After excise taxes and contributions to a replacement employee plan, Kodak projects receiving proceeds between $530 million and $585 million.
- Debt Prepayment Obligation: Kodak is obligated to use 100% of net reversion proceeds to prepay term loans until the balance reaches $300 million, then 50% until $200 million. This is estimated to require approximately $315 million of proceeds.
- Net Cash Available to Kodak: After mandatory debt prepayments, Kodak projects receiving between $215 million and $270 million for strategic growth or general corporate purposes.
Material Changes and Strategic Actions
The filing represents a significant shift in the management of Kodak's pension assets:
- Asset Liquidation: The Trust has initiated a secondary sale process to convert illiquid private equity interests into cash.
- Plan Termination Review: The Board of Directors is reviewing options to terminate KRIP. No formal determination has been made yet.
- Liability Satisfaction Strategy: If terminated, liabilities will be satisfied via lump-sum distributions to participants and the purchase of annuities for retirees.
- Debt Reduction: The transaction is structured to significantly reduce Kodak's term loan balance, potentially lowering annual interest costs by approximately $40 million.
Guidance, Outlook, and Risks
Timeline: Kodak estimates 12 to 18 months to determine and satisfy liabilities, and 18 to 24 months to receive reversion proceeds from the date of a formal termination determination.
Key Risks and Contingencies:
- Transaction Failure: Risk that sale agreements may not close due to failed conditions or lack of counterparty consent.
- Regulatory and Legal: Potential delays or changes in laws regarding plan termination, asset monetization, and tax treatment.
- Actuarial Variables: The final surplus amount depends on interest rate fluctuations, annuity costs, and participant election choices (lump sum vs. annuity).
- Market Conditions: Adverse changes in debt, equity, or insurance markets could impact asset values and liability costs.
- Excise Tax: Kodak plans to contribute 25% of surplus assets to a replacement plan to reduce the excise tax rate from 50% to 20%.
Investor Verification Checklist
- Confirm the formal Board determination to terminate KRIP, as the current status is under review.
- Verify the closing of the $550.6 million sale to Mastercard Foundation and the subsequent sales to other investors.
- Monitor the actual redemption proceeds from the $917.2 million in hedge fund assets.
- Track the final actuarial valuation of KRIP liabilities, which will determine the actual surplus available for reversion.
- Assess the impact of the projected $315 million debt prepayment on Kodak's liquidity and leverage ratios.
- Review any regulatory approvals required for the plan termination and asset reversion process.